Last $32.81 USD
Change Today +0.74 / 2.31%
Volume 231.3K
THOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

thoratec corp (THOR) Snapshot

Open
$32.09
Previous Close
$32.07
Day High
$33.05
Day Low
$32.09
52 Week High
01/15/14 - $38.69
52 Week Low
08/7/14 - $22.50
Market Cap
1.8B
Average Volume 10 Days
741.8K
EPS TTM
$0.99
Shares Outstanding
55.0M
EX-Date
--
P/E TM
33.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for THORATEC CORP (THOR)

thoratec corp (THOR) Related Businessweek News

No Related Businessweek News Found

thoratec corp (THOR) Details

Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure; and PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. In addition, the company provides Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising home discharge and post-cardiotomy myocardial recovery. It sells its products through direct sales force and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

951 Employees
Last Reported Date: 02/18/14
Founded in 1976

thoratec corp (THOR) Top Compensated Officers

Chief Financial Officer and Vice President
Total Annual Compensation: $302.3K
Senior Vice President and General Counsel
Total Annual Compensation: $338.3K
Advisor
Total Annual Compensation: $570.7K
Compensation as of Fiscal Year 2013.

thoratec corp (THOR) Key Developments

Thoratec Corp. Announces Completion of Enrollment in the Heartmate III CE Mark Trial

Thoratec Corp. announced completion of enrollment in the HeartMate III CE Mark trial. This trial enrolled a total of 50 patients at ten sites across Europe, Canada, and Australia. HeartMate III is a centrifugal-flow chronic left ventricular assist system utilizing a fully magnetically levitated technology foundation designed to lower adverse event rates while also enhancing the ease of surgical placement through a compact size. The CE Mark trial will evaluate patient survival with a six-month follow up period, which will be reached in May 2015. Thoratec continues to expect regulatory submission of CE Mark data next year, with an approval and commercial launch in late 2015.

Thoratec Corp. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 11:30 AM

Thoratec Corp. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 11:30 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Keith Grossman, President and Chief Executive Officer.

Thoratec Corp. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 01:35 PM

Thoratec Corp. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 01:35 PM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Taylor C. Harris, Chief Financial Officer and Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THOR:US $32.81 USD +0.74

THOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $54.63 USD +0.48
ICU Medical Inc $83.38 USD +1.63
Merit Medical Systems Inc $17.17 USD +0.01
Tornier NV $25.68 USD +0.13
Wright Medical Group Inc $26.65 USD -0.02
View Industry Companies
 

Industry Analysis

THOR

Industry Average

Valuation THOR Industry Range
Price/Earnings 36.3x
Price/Sales 3.8x
Price/Book 2.8x
Price/Cash Flow 34.8x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THORATEC CORP, please visit www.thoratec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.